Category: Warning/Recalls Region: Asia · India Company: Natco Pharma Ltd

Usfda Issues 6 Observations To Natco Pharmas Api Facility Near Hyderabad

Usfda Issues 6 Observations To Natco Pharmas Api Facility Near Hyderabad
New Delhi: Natco Pharma On Monday Said The Us Health Regulator Has Made Six Observations After The Completion Of Inspection Of Active Pharmaceutical Ingredient (Api) Facility In Mekaguda Village, Near Hyderabad.The United States Food And Drug Administration (Usfda) Conducted Inspection At Kothur Facility Between August 5-9, 2019.

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!